Silvia Giordano Selected Research

Silvia Giordano Research Topics

Disease

65	Neoplasms (Cancer) 04/2024 - 03/2003
13	Stomach Neoplasms (Stomach Cancer) 06/2023 - 05/2010
12	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2003
8	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 06/2011
6	Melanoma (Melanoma, Malignant) 01/2022 - 12/2008
6	Neoplasm Metastasis (Metastasis) 12/2020 - 07/2004
5	Adenocarcinoma 04/2024 - 01/2021
5	Carcinogenesis 09/2023 - 05/2006
4	Carcinoma (Carcinomatosis) 01/2018 - 07/2004
3	Hyperplasia 08/2023 - 11/2011
3	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 06/2013
3	Colonic Neoplasms (Colon Cancer) 01/2018 - 02/2012
3	Lung Neoplasms (Lung Cancer) 12/2017 - 12/2014
2	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 08/2013
2	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 12/2016
2	Amnesia (Dissociative Amnesia) 01/2023 - 01/2018
2	Adenoma (Adenomas) 01/2022 - 01/2018
2	Lymphoma (Lymphomas) 01/2021 - 01/2018
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2019 - 03/2003
2	Malignant Mesothelioma 11/2017 - 12/2016
2	Infections 04/2005 - 11/2003
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2024
1	Gastroesophageal Reflux (GERD) 12/2023
1	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023
1	Skin Neoplasms (Skin Cancer) 01/2023
1	Intestinal Neoplasms (Intestinal Cancer) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022

Drug/Important Bio-Agent (IBA)

11	Phosphotransferases (Kinase)IBA 09/2023 - 01/2009
10	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2005
10	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 03/2022 - 04/2005
8	Trastuzumab (Herceptin)FDA Link 06/2023 - 04/2005
8	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2014 - 04/2003
7	MicroRNAs (MicroRNA)IBA 04/2022 - 12/2008
6	Tyrosine Kinase InhibitorsIBA 01/2021 - 08/2013
5	ErbB Receptors (EGF Receptor)IBA 10/2020 - 07/2004
5	LigandsIBA 08/2020 - 07/2004
4	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 01/2018
4	Messenger RNA (mRNA)IBA 04/2022 - 12/2005
4	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2018
4	Monoclonal AntibodiesIBA 12/2014 - 04/2005
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 01/2016
3	tyrosine receptor (receptor, tyrosine)IBA 12/2018 - 01/2009
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2015 - 04/2003
3	Transcription Factors (Transcription Factor)IBA 01/2014 - 07/2005
3	Tyrosine (L-Tyrosine)FDA Link 05/2010 - 07/2004
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024 - 01/2023
2	MitogensIBA 08/2023 - 06/2011
2	Triiodothyronine (Liothyronine)FDA LinkGeneric 08/2023 - 01/2020
2	pertuzumabIBA 01/2023 - 01/2021
2	olaparibIBA 01/2023 - 01/2020
2	4-hexyloxyaniline (HOA)IBA 05/2022 - 03/2022
2	Thyroid HormonesIBA 01/2022 - 01/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2016
2	Hormones (Hormone)IBA 01/2022 - 08/2013
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2018
2	Lapatinib (GW572016)FDA Link 01/2021 - 11/2011
2	Neuropilin-1IBA 08/2020 - 01/2018
2	AntagomirsIBA 02/2012 - 12/2008
2	1,4- bis(2- (3,5- dichloropyridyloxy))benzeneIBA 11/2011 - 06/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2011 - 07/2004
2	CD100 antigenIBA 07/2008 - 03/2003
2	Estrogen Receptor alphaIBA 07/2005 - 06/2004
2	plexinIBA 07/2004 - 03/2003
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 04/2024
1	Bile Acids and Salts (Bile Acids)IBA 12/2023
1	Cadherins (E-Cadherin)IBA 12/2023
1	guselkumabIBA 12/2023
1	tildrakizumabIBA 12/2023
1	Interleukin-17 (Interleukin 17)IBA 12/2023
1	Interleukin-23 (Interleukin 23)IBA 12/2023
1	Docetaxel (Taxotere)FDA Link 09/2023
1	lead nitrateIBA 08/2023
1	Nucleic AcidsIBA 08/2023
1	NAD (NADH)IBA 08/2023
1	Amino Acids FDA Link 08/2023
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 06/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2022
1	ChemokinesIBA 11/2022
1	Chimeric Antigen ReceptorsIBA 10/2022
1	NivolumabIBA 01/2022
1	Retroelements (Retrotransposon)IBA 01/2022
1	Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA 01/2022
1	Clofarabine (Clolar)FDA Link 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	Melanins (Melanin)IBA 01/2022
1	Kelch-Like ECH-Associated Protein 1IBA 01/2022
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 01/2022
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2021
1	Everolimus FDA Link 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021

Therapy/Procedure

32	Therapeutics 04/2024 - 06/2005
4	Drug Therapy (Chemotherapy) 01/2023 - 01/2011
2	Hepatectomy 08/2023 - 11/2011
2	Transplantation 01/2021 - 02/2014
1	Tattooing 01/2023
1	Immunotherapy 10/2022
1	Aftercare (After-Treatment) 03/2022
1	Breast Implants (Breast Implant) 01/2021